ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Next-Generation Tumor Genetic Testing Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-0W17142
Home | Market Reports | Science| Biological Sciences
Global Next Generation Tumor Genetic Testing Market Research Report 2024
BUY CHAPTERS

Global Next-Generation Tumor Genetic Testing Market Research Report 2025

Code: QYRE-Auto-0W17142
Report
September 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Personal Genome Diagnostics
Veracyte, Inc. 
Pacific Biosciences of California
Qiagen NV
Agilent Technologies
Natera
Bio Rad Laboratories
Myriad Genetics

Next-Generation Tumor Genetic Testing Market

The global market for Next-Generation Tumor Genetic Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Next-Generation Tumor Genetic Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Next-Generation Tumor Genetic Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Next-Generation Tumor Genetic Testing in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Next-Generation Tumor Genetic Testing include Devyser, Agendia, Illumina, Personal Genome Diagnostics, Veracyte, Pacific Biosciences of California, Qiagen, Agilent Technologies, Natera, Bio Rad Laboratories, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Next-Generation Tumor Genetic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next-Generation Tumor Genetic Testing.
The Next-Generation Tumor Genetic Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Next-Generation Tumor Genetic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Next-Generation Tumor Genetic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Next-Generation Tumor Genetic Testing Market Report

Report Metric Details
Report Name Next-Generation Tumor Genetic Testing Market
Segment by Type
  • Fluorescence In Situ Hybridization
  • Polymerase Chain Reaction
  • Microarray Technology
  • Serum Proteomics
  • Nucleic Acid Sequencing
Segment by Application
  • Hospitals
  • Speciality Clinics
  • Research Institutes
  • Diagnostics Laboratories
  • Biopharmaceutical Companies
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Devyser, Agendia, Illumina, Personal Genome Diagnostics, Veracyte, Pacific Biosciences of California, Qiagen, Agilent Technologies, Natera, Bio Rad Laboratories, Myriad Genetics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Next-Generation Tumor Genetic Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Next-Generation Tumor Genetic Testing Market report?

Ans: The main players in the Next-Generation Tumor Genetic Testing Market are Devyser, Agendia, Illumina, Personal Genome Diagnostics, Veracyte, Pacific Biosciences of California, Qiagen, Agilent Technologies, Natera, Bio Rad Laboratories, Myriad Genetics

What are the Application segmentation covered in the Next-Generation Tumor Genetic Testing Market report?

Ans: The Applications covered in the Next-Generation Tumor Genetic Testing Market report are Hospitals, Speciality Clinics, Research Institutes, Diagnostics Laboratories, Biopharmaceutical Companies

What are the Type segmentation covered in the Next-Generation Tumor Genetic Testing Market report?

Ans: The Types covered in the Next-Generation Tumor Genetic Testing Market report are Fluorescence In Situ Hybridization, Polymerase Chain Reaction, Microarray Technology, Serum Proteomics, Nucleic Acid Sequencing

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next-Generation Tumor Genetic Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Fluorescence In Situ Hybridization
1.2.3 Polymerase Chain Reaction
1.2.4 Microarray Technology
1.2.5 Serum Proteomics
1.2.6 Nucleic Acid Sequencing
1.3 Market by Application
1.3.1 Global Next-Generation Tumor Genetic Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Speciality Clinics
1.3.4 Research Institutes
1.3.5 Diagnostics Laboratories
1.3.6 Biopharmaceutical Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Next-Generation Tumor Genetic Testing Market Perspective (2020-2031)
2.2 Global Next-Generation Tumor Genetic Testing Growth Trends by Region
2.2.1 Global Next-Generation Tumor Genetic Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Next-Generation Tumor Genetic Testing Historic Market Size by Region (2020-2025)
2.2.3 Next-Generation Tumor Genetic Testing Forecasted Market Size by Region (2026-2031)
2.3 Next-Generation Tumor Genetic Testing Market Dynamics
2.3.1 Next-Generation Tumor Genetic Testing Industry Trends
2.3.2 Next-Generation Tumor Genetic Testing Market Drivers
2.3.3 Next-Generation Tumor Genetic Testing Market Challenges
2.3.4 Next-Generation Tumor Genetic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Next-Generation Tumor Genetic Testing Players by Revenue
3.1.1 Global Top Next-Generation Tumor Genetic Testing Players by Revenue (2020-2025)
3.1.2 Global Next-Generation Tumor Genetic Testing Revenue Market Share by Players (2020-2025)
3.2 Global Next-Generation Tumor Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Next-Generation Tumor Genetic Testing Revenue
3.4 Global Next-Generation Tumor Genetic Testing Market Concentration Ratio
3.4.1 Global Next-Generation Tumor Genetic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next-Generation Tumor Genetic Testing Revenue in 2024
3.5 Global Key Players of Next-Generation Tumor Genetic Testing Head office and Area Served
3.6 Global Key Players of Next-Generation Tumor Genetic Testing, Product and Application
3.7 Global Key Players of Next-Generation Tumor Genetic Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Next-Generation Tumor Genetic Testing Breakdown Data by Type
4.1 Global Next-Generation Tumor Genetic Testing Historic Market Size by Type (2020-2025)
4.2 Global Next-Generation Tumor Genetic Testing Forecasted Market Size by Type (2026-2031)
5 Next-Generation Tumor Genetic Testing Breakdown Data by Application
5.1 Global Next-Generation Tumor Genetic Testing Historic Market Size by Application (2020-2025)
5.2 Global Next-Generation Tumor Genetic Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Next-Generation Tumor Genetic Testing Market Size (2020-2031)
6.2 North America Next-Generation Tumor Genetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Next-Generation Tumor Genetic Testing Market Size by Country (2020-2025)
6.4 North America Next-Generation Tumor Genetic Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Next-Generation Tumor Genetic Testing Market Size (2020-2031)
7.2 Europe Next-Generation Tumor Genetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Next-Generation Tumor Genetic Testing Market Size by Country (2020-2025)
7.4 Europe Next-Generation Tumor Genetic Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Next-Generation Tumor Genetic Testing Market Size (2020-2031)
8.2 Asia-Pacific Next-Generation Tumor Genetic Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Next-Generation Tumor Genetic Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Next-Generation Tumor Genetic Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Next-Generation Tumor Genetic Testing Market Size (2020-2031)
9.2 Latin America Next-Generation Tumor Genetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Next-Generation Tumor Genetic Testing Market Size by Country (2020-2025)
9.4 Latin America Next-Generation Tumor Genetic Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Next-Generation Tumor Genetic Testing Market Size (2020-2031)
10.2 Middle East & Africa Next-Generation Tumor Genetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Next-Generation Tumor Genetic Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Next-Generation Tumor Genetic Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Devyser
11.1.1 Devyser Company Details
11.1.2 Devyser Business Overview
11.1.3 Devyser Next-Generation Tumor Genetic Testing Introduction
11.1.4 Devyser Revenue in Next-Generation Tumor Genetic Testing Business (2020-2025)
11.1.5 Devyser Recent Development
11.2 Agendia
11.2.1 Agendia Company Details
11.2.2 Agendia Business Overview
11.2.3 Agendia Next-Generation Tumor Genetic Testing Introduction
11.2.4 Agendia Revenue in Next-Generation Tumor Genetic Testing Business (2020-2025)
11.2.5 Agendia Recent Development
11.3 Illumina
11.3.1 Illumina Company Details
11.3.2 Illumina Business Overview
11.3.3 Illumina Next-Generation Tumor Genetic Testing Introduction
11.3.4 Illumina Revenue in Next-Generation Tumor Genetic Testing Business (2020-2025)
11.3.5 Illumina Recent Development
11.4 Personal Genome Diagnostics
11.4.1 Personal Genome Diagnostics Company Details
11.4.2 Personal Genome Diagnostics Business Overview
11.4.3 Personal Genome Diagnostics Next-Generation Tumor Genetic Testing Introduction
11.4.4 Personal Genome Diagnostics Revenue in Next-Generation Tumor Genetic Testing Business (2020-2025)
11.4.5 Personal Genome Diagnostics Recent Development
11.5 Veracyte
11.5.1 Veracyte Company Details
11.5.2 Veracyte Business Overview
11.5.3 Veracyte Next-Generation Tumor Genetic Testing Introduction
11.5.4 Veracyte Revenue in Next-Generation Tumor Genetic Testing Business (2020-2025)
11.5.5 Veracyte Recent Development
11.6 Pacific Biosciences of California
11.6.1 Pacific Biosciences of California Company Details
11.6.2 Pacific Biosciences of California Business Overview
11.6.3 Pacific Biosciences of California Next-Generation Tumor Genetic Testing Introduction
11.6.4 Pacific Biosciences of California Revenue in Next-Generation Tumor Genetic Testing Business (2020-2025)
11.6.5 Pacific Biosciences of California Recent Development
11.7 Qiagen
11.7.1 Qiagen Company Details
11.7.2 Qiagen Business Overview
11.7.3 Qiagen Next-Generation Tumor Genetic Testing Introduction
11.7.4 Qiagen Revenue in Next-Generation Tumor Genetic Testing Business (2020-2025)
11.7.5 Qiagen Recent Development
11.8 Agilent Technologies
11.8.1 Agilent Technologies Company Details
11.8.2 Agilent Technologies Business Overview
11.8.3 Agilent Technologies Next-Generation Tumor Genetic Testing Introduction
11.8.4 Agilent Technologies Revenue in Next-Generation Tumor Genetic Testing Business (2020-2025)
11.8.5 Agilent Technologies Recent Development
11.9 Natera
11.9.1 Natera Company Details
11.9.2 Natera Business Overview
11.9.3 Natera Next-Generation Tumor Genetic Testing Introduction
11.9.4 Natera Revenue in Next-Generation Tumor Genetic Testing Business (2020-2025)
11.9.5 Natera Recent Development
11.10 Bio Rad Laboratories
11.10.1 Bio Rad Laboratories Company Details
11.10.2 Bio Rad Laboratories Business Overview
11.10.3 Bio Rad Laboratories Next-Generation Tumor Genetic Testing Introduction
11.10.4 Bio Rad Laboratories Revenue in Next-Generation Tumor Genetic Testing Business (2020-2025)
11.10.5 Bio Rad Laboratories Recent Development
11.11 Myriad Genetics
11.11.1 Myriad Genetics Company Details
11.11.2 Myriad Genetics Business Overview
11.11.3 Myriad Genetics Next-Generation Tumor Genetic Testing Introduction
11.11.4 Myriad Genetics Revenue in Next-Generation Tumor Genetic Testing Business (2020-2025)
11.11.5 Myriad Genetics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Personal Genome Diagnostics
Veracyte, Inc. 
Pacific Biosciences of California
Qiagen NV
Agilent Technologies
Natera
Bio Rad Laboratories
Myriad Genetics
List of Tables
 Table 1. Global Next-Generation Tumor Genetic Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Fluorescence In Situ Hybridization
 Table 3. Key Players of Polymerase Chain Reaction
 Table 4. Key Players of Microarray Technology
 Table 5. Key Players of Serum Proteomics
 Table 6. Key Players of Nucleic Acid Sequencing
 Table 7. Global Next-Generation Tumor Genetic Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Next-Generation Tumor Genetic Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Next-Generation Tumor Genetic Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Next-Generation Tumor Genetic Testing Market Share by Region (2020-2025)
 Table 11. Global Next-Generation Tumor Genetic Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Next-Generation Tumor Genetic Testing Market Share by Region (2026-2031)
 Table 13. Next-Generation Tumor Genetic Testing Market Trends
 Table 14. Next-Generation Tumor Genetic Testing Market Drivers
 Table 15. Next-Generation Tumor Genetic Testing Market Challenges
 Table 16. Next-Generation Tumor Genetic Testing Market Restraints
 Table 17. Global Next-Generation Tumor Genetic Testing Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Next-Generation Tumor Genetic Testing Market Share by Players (2020-2025)
 Table 19. Global Top Next-Generation Tumor Genetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next-Generation Tumor Genetic Testing as of 2024)
 Table 20. Ranking of Global Top Next-Generation Tumor Genetic Testing Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Next-Generation Tumor Genetic Testing Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Next-Generation Tumor Genetic Testing, Headquarters and Area Served
 Table 23. Global Key Players of Next-Generation Tumor Genetic Testing, Product and Application
 Table 24. Global Key Players of Next-Generation Tumor Genetic Testing, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Next-Generation Tumor Genetic Testing Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Next-Generation Tumor Genetic Testing Revenue Market Share by Type (2020-2025)
 Table 28. Global Next-Generation Tumor Genetic Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Next-Generation Tumor Genetic Testing Revenue Market Share by Type (2026-2031)
 Table 30. Global Next-Generation Tumor Genetic Testing Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Next-Generation Tumor Genetic Testing Revenue Market Share by Application (2020-2025)
 Table 32. Global Next-Generation Tumor Genetic Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Next-Generation Tumor Genetic Testing Revenue Market Share by Application (2026-2031)
 Table 34. North America Next-Generation Tumor Genetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Next-Generation Tumor Genetic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Next-Generation Tumor Genetic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Next-Generation Tumor Genetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Next-Generation Tumor Genetic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Next-Generation Tumor Genetic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Next-Generation Tumor Genetic Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Next-Generation Tumor Genetic Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Next-Generation Tumor Genetic Testing Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Next-Generation Tumor Genetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Next-Generation Tumor Genetic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Next-Generation Tumor Genetic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Next-Generation Tumor Genetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Next-Generation Tumor Genetic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Next-Generation Tumor Genetic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Devyser Company Details
 Table 50. Devyser Business Overview
 Table 51. Devyser Next-Generation Tumor Genetic Testing Product
 Table 52. Devyser Revenue in Next-Generation Tumor Genetic Testing Business (2020-2025) & (US$ Million)
 Table 53. Devyser Recent Development
 Table 54. Agendia Company Details
 Table 55. Agendia Business Overview
 Table 56. Agendia Next-Generation Tumor Genetic Testing Product
 Table 57. Agendia Revenue in Next-Generation Tumor Genetic Testing Business (2020-2025) & (US$ Million)
 Table 58. Agendia Recent Development
 Table 59. Illumina Company Details
 Table 60. Illumina Business Overview
 Table 61. Illumina Next-Generation Tumor Genetic Testing Product
 Table 62. Illumina Revenue in Next-Generation Tumor Genetic Testing Business (2020-2025) & (US$ Million)
 Table 63. Illumina Recent Development
 Table 64. Personal Genome Diagnostics Company Details
 Table 65. Personal Genome Diagnostics Business Overview
 Table 66. Personal Genome Diagnostics Next-Generation Tumor Genetic Testing Product
 Table 67. Personal Genome Diagnostics Revenue in Next-Generation Tumor Genetic Testing Business (2020-2025) & (US$ Million)
 Table 68. Personal Genome Diagnostics Recent Development
 Table 69. Veracyte Company Details
 Table 70. Veracyte Business Overview
 Table 71. Veracyte Next-Generation Tumor Genetic Testing Product
 Table 72. Veracyte Revenue in Next-Generation Tumor Genetic Testing Business (2020-2025) & (US$ Million)
 Table 73. Veracyte Recent Development
 Table 74. Pacific Biosciences of California Company Details
 Table 75. Pacific Biosciences of California Business Overview
 Table 76. Pacific Biosciences of California Next-Generation Tumor Genetic Testing Product
 Table 77. Pacific Biosciences of California Revenue in Next-Generation Tumor Genetic Testing Business (2020-2025) & (US$ Million)
 Table 78. Pacific Biosciences of California Recent Development
 Table 79. Qiagen Company Details
 Table 80. Qiagen Business Overview
 Table 81. Qiagen Next-Generation Tumor Genetic Testing Product
 Table 82. Qiagen Revenue in Next-Generation Tumor Genetic Testing Business (2020-2025) & (US$ Million)
 Table 83. Qiagen Recent Development
 Table 84. Agilent Technologies Company Details
 Table 85. Agilent Technologies Business Overview
 Table 86. Agilent Technologies Next-Generation Tumor Genetic Testing Product
 Table 87. Agilent Technologies Revenue in Next-Generation Tumor Genetic Testing Business (2020-2025) & (US$ Million)
 Table 88. Agilent Technologies Recent Development
 Table 89. Natera Company Details
 Table 90. Natera Business Overview
 Table 91. Natera Next-Generation Tumor Genetic Testing Product
 Table 92. Natera Revenue in Next-Generation Tumor Genetic Testing Business (2020-2025) & (US$ Million)
 Table 93. Natera Recent Development
 Table 94. Bio Rad Laboratories Company Details
 Table 95. Bio Rad Laboratories Business Overview
 Table 96. Bio Rad Laboratories Next-Generation Tumor Genetic Testing Product
 Table 97. Bio Rad Laboratories Revenue in Next-Generation Tumor Genetic Testing Business (2020-2025) & (US$ Million)
 Table 98. Bio Rad Laboratories Recent Development
 Table 99. Myriad Genetics Company Details
 Table 100. Myriad Genetics Business Overview
 Table 101. Myriad Genetics Next-Generation Tumor Genetic Testing Product
 Table 102. Myriad Genetics Revenue in Next-Generation Tumor Genetic Testing Business (2020-2025) & (US$ Million)
 Table 103. Myriad Genetics Recent Development
 Table 104. Research Programs/Design for This Report
 Table 105. Key Data Information from Secondary Sources
 Table 106. Key Data Information from Primary Sources
 Table 107. Authors List of This Report


List of Figures
 Figure 1. Next-Generation Tumor Genetic Testing Picture
 Figure 2. Global Next-Generation Tumor Genetic Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Next-Generation Tumor Genetic Testing Market Share by Type: 2024 VS 2031
 Figure 4. Fluorescence In Situ Hybridization Features
 Figure 5. Polymerase Chain Reaction Features
 Figure 6. Microarray Technology Features
 Figure 7. Serum Proteomics Features
 Figure 8. Nucleic Acid Sequencing Features
 Figure 9. Global Next-Generation Tumor Genetic Testing Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Next-Generation Tumor Genetic Testing Market Share by Application: 2024 VS 2031
 Figure 11. Hospitals Case Studies
 Figure 12. Speciality Clinics Case Studies
 Figure 13. Research Institutes Case Studies
 Figure 14. Diagnostics Laboratories Case Studies
 Figure 15. Biopharmaceutical Companies Case Studies
 Figure 16. Next-Generation Tumor Genetic Testing Report Years Considered
 Figure 17. Global Next-Generation Tumor Genetic Testing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 18. Global Next-Generation Tumor Genetic Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Next-Generation Tumor Genetic Testing Market Share by Region: 2024 VS 2031
 Figure 20. Global Next-Generation Tumor Genetic Testing Market Share by Players in 2024
 Figure 21. Global Top Next-Generation Tumor Genetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next-Generation Tumor Genetic Testing as of 2024)
 Figure 22. The Top 10 and 5 Players Market Share by Next-Generation Tumor Genetic Testing Revenue in 2024
 Figure 23. North America Next-Generation Tumor Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. North America Next-Generation Tumor Genetic Testing Market Share by Country (2020-2031)
 Figure 25. United States Next-Generation Tumor Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Canada Next-Generation Tumor Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Next-Generation Tumor Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Next-Generation Tumor Genetic Testing Market Share by Country (2020-2031)
 Figure 29. Germany Next-Generation Tumor Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. France Next-Generation Tumor Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. U.K. Next-Generation Tumor Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Italy Next-Generation Tumor Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Russia Next-Generation Tumor Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Nordic Countries Next-Generation Tumor Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Next-Generation Tumor Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Next-Generation Tumor Genetic Testing Market Share by Region (2020-2031)
 Figure 37. China Next-Generation Tumor Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Japan Next-Generation Tumor Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. South Korea Next-Generation Tumor Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Next-Generation Tumor Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. India Next-Generation Tumor Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Australia Next-Generation Tumor Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Next-Generation Tumor Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Next-Generation Tumor Genetic Testing Market Share by Country (2020-2031)
 Figure 45. Mexico Next-Generation Tumor Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Brazil Next-Generation Tumor Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Next-Generation Tumor Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Next-Generation Tumor Genetic Testing Market Share by Country (2020-2031)
 Figure 49. Turkey Next-Generation Tumor Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Next-Generation Tumor Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. UAE Next-Generation Tumor Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Devyser Revenue Growth Rate in Next-Generation Tumor Genetic Testing Business (2020-2025)
 Figure 53. Agendia Revenue Growth Rate in Next-Generation Tumor Genetic Testing Business (2020-2025)
 Figure 54. Illumina Revenue Growth Rate in Next-Generation Tumor Genetic Testing Business (2020-2025)
 Figure 55. Personal Genome Diagnostics Revenue Growth Rate in Next-Generation Tumor Genetic Testing Business (2020-2025)
 Figure 56. Veracyte Revenue Growth Rate in Next-Generation Tumor Genetic Testing Business (2020-2025)
 Figure 57. Pacific Biosciences of California Revenue Growth Rate in Next-Generation Tumor Genetic Testing Business (2020-2025)
 Figure 58. Qiagen Revenue Growth Rate in Next-Generation Tumor Genetic Testing Business (2020-2025)
 Figure 59. Agilent Technologies Revenue Growth Rate in Next-Generation Tumor Genetic Testing Business (2020-2025)
 Figure 60. Natera Revenue Growth Rate in Next-Generation Tumor Genetic Testing Business (2020-2025)
 Figure 61. Bio Rad Laboratories Revenue Growth Rate in Next-Generation Tumor Genetic Testing Business (2020-2025)
 Figure 62. Myriad Genetics Revenue Growth Rate in Next-Generation Tumor Genetic Testing Business (2020-2025)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Cancer Genomic Testing Market Research Report 2024
Global Genomic Testing in Cancer Market Research Report 2024
Global Tumor Gene Test Service Market Research Report 2025
Global Breast Cancer Predictive Genetic Testing Market Research Report 2024
Cancer Gene Testing Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Next Generation Cancer Diagnostics Market
Global Lung Cancer Genomic Testing Market Research Report 2024
Global Inherited Cancer Genome Testing Market Research Report 2024
Global Genotyping Test Market Research Report 2025
Global DNA Genetic Testing Market Research Report 2024
Global Predictive Genetic Testing And Consumer Genomics Market Research Report 2024
Rare Disease Genetic Testing Market
Global Tumor NGS Genetic Testing Market Research Report 2024
Global Tumor Biomarker Test Market Research Report 2024
Global Cancer Oncology Testing Market Research Report 2024
Global HPV Genetic Testing Market Research Report 2025
Global Gene Detection for Individualized Cancer Therapy Market Research Report 2024
Global Hereditary Disease Testing Market Research Report 2024
Global Thyroid Nodule Genetic Testing Market Research Report 2024
Global Genetic Disease Diagnostic Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions